Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

6825 ARTÍCULOS , VIENDO DEL 5146 AL 5160

Blood markers of oxidative stress in Alzheimer's disease

Skoumalová A, Hort J.

J Cell Mol Med. 2012 Oct;16(10):2291-300. doi: 10.1111/j.1582-4934.2012.01585.x.

[The new 2011 recommendations of the National Institute on Aging and the Alzheimer's Association on diagnostic guidelines for Alzheimer's disease: Preclinal stages, mild cognitive impairment, and dementia]

Croisile B, Auriacombe S, Etcharry-Bouyx F, Vercelletto M; National Institute on Aging (u.s.); Alzheimer Association.

Rev Neurol (Paris). 2012 Jun;168(6-7):471-82. doi: 10.1016/j.neurol.2011.11.007. Epub 2012 May 12.

Alzheimer's disease: biological aspects, therapeutic perspectives and diagnostic tools

Di Carlo M, Giacomazza D, San Biagio PL.

J Phys Condens Matter. 2012 Jun 20;24(24):244102. doi: 10.1088/0953-8984/24/24/244102. Epub 2012 May 18.

[Searching for biomarkers to diagnose dementia]

Yanagisawa K.

Nihon Rinsho. 2012 May;70(5):785-9.

Biomarkers of neurodegeneration - not only Alzheimer's disease and not only cerebrospinal fluid: a guest-editor's introduction

Lewczuk P.

J Neural Transm (Vienna). 2012 Jul;119(7):735-7. doi: 10.1007/s00702-012-0836-5.

The development of effective biomarkers for Alzheimer's disease: a review

Henry MS, Passmore AP, Todd S, McGuinness B, Craig D, Johnston JA.

Int J Geriatr Psychiatry. 2013 Apr;28(4):331-40. doi: 10.1002/gps.3829. Epub 2012 Jun 4.

Prospective interest of molecular neuroimaging in Alzheimer's disease

Guedj E.

Rev Neurol (Paris). 2013 Jan;169(1):9-13. doi: 10.1016/j.neurol.2012.03.007. Epub 2012 Jun 6.

Dealing with uncertainty: biomarkers for the early detection of Alzheimer's disease

Perneczky R, Kurz A.

Int Psychogeriatr. 2012 Oct;24(10):1533-5. doi: 10.1017/S1041610212001056. Epub 2012 Jun 12.

The exception makes the rule: not all Aβ plaques are created equal

Ringman JM, Teplow DB, Villemagne VL.

Neurology. 2012 Jul 17;79(3):206-7. doi: 10.1212/WNL.0b013e31825fe11f. Epub 2012 Jun 13.

Retinal pathology as biomarker for cognitive impairment and Alzheimer's disease

Ikram MK, Cheung CY, Wong TY, Chen CP.

J Neurol Neurosurg Psychiatry. 2012 Sep;83(9):917-22. doi: 10.1136/jnnp-2011-301628. Epub 2012 Jun 25.

Blood and plasma-based proteomic biomarker research in Alzheimer's disease

Lista S, Faltraco F, Prvulovic D, Hampel H.

Prog Neurobiol. 2013 Feb-Mar;101-102:1-17. doi: 10.1016/j.pneurobio.2012.06.007. Epub 2012 Jun 26.

Development of biomarkers to chart all Alzheimer's disease stages: the royal road to cutting the therapeutic Gordian Knot

Hampel H, Lista S, Khachaturian ZS.

Alzheimers Dement. 2012 Jul;8(4):312-36. doi: 10.1016/j.jalz.2012.05.2116.

The effects of ramipril in individuals at risk for Alzheimer's disease: results of a pilot clinical trial

Wharton W, Stein JH, Korcarz C, Sachs J, Olson SR, Zetterberg H, Dowling M, Ye S, Gleason CE, Underbakke G, Jacobson LE, Johnson SC, Sager MA, Asthana S, Carlsson CM.

J Alzheimers Dis. 2012;32(1):147-56. doi: 10.3233/JAD-2012-120763.

Comparison of imaging biomarkers in the Alzheimer Disease Neuroimaging Initiative and the Mayo Clinic Study of Aging

Whitwell JL, Wiste HJ, Weigand SD, Rocca WA, Knopman DS, Roberts RO, Boeve BF, Petersen RC, Jack CR Jr; Alzheimer Disease Neuroimaging Initiative.

Arch Neurol. 2012 May;69(5):614-22. doi: 10.1001/archneurol.2011.3029.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias